VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 125 filers reported holding VOYAGER THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.17 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $102,827 | -29.2% | 13,268 | +4.6% | 0.00% | – |
| Q2 2023 | $145,232 | +120.0% | 12,684 | -10.0% | 0.00% | – |
| Q1 2021 | $66,000 | -16.5% | 14,094 | +27.5% | 0.00% | – |
| Q4 2020 | $79,000 | -30.1% | 11,053 | -10.2% | 0.00% | – |
| Q1 2020 | $113,000 | -34.3% | 12,312 | 0.0% | 0.00% | – |
| Q4 2019 | $172,000 | -34.4% | 12,312 | +28.0% | 0.00% | -100.0% |
| Q2 2019 | $262,000 | – | 9,619 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $109,992,000 | 62.32% |
| Foresite Capital Management IV, LLC | 830,565 | $14,294,000 | 4.62% |
| Casdin Capital, LLC | 1,128,075 | $19,414,171,000 | 2.01% |
| ARMISTICE CAPITAL, LLC | 1,096,000 | $18,862,000 | 1.25% |
| Bellevue Group AG | 2,704,683 | $46,548,000 | 0.87% |
| PFM Health Sciences, LP | 1,231,954 | $21,202,000 | 0.63% |
| Boxer Capital, LLC | 500,000 | $8,605,000 | 0.62% |
| Aevitas Wealth Management, Inc. | 23,150 | $398,000 | 0.40% |
| 361 CAPITAL LLC | 120,143 | $2,068,000 | 0.38% |
| Birchview Capital, LP | 30,000 | $516,000 | 0.34% |